Learn about the specific actions we’re taking to protect and improve state and federal policies that are critical to the health and well-being of people living with autoimmune disease and their families.
Comments to CMS on Proposed Implementation of the Inflation Reduction Act
April 2023 – The Autoimmune Association submitted comments submitted to the Center for Medicare and Medicaid Services (CMS) within the Department of Health and Human Services (HHS) on their proposed implementation of the Inflation Reduction Act. The comments express the position of the autoimmune patient community that implementation needs to consider patient access beyond coverage, expand the definition of unmet need, and allow more time for stakeholder input.
Letter in Support of New Mexico H.B. 73 Biomarker Testing Insurance Requirements
March 2023 – The Autoimmune Association sent a letter to the office of New Mexico Governor Michelle Lujan Grisham urging her to sign New Mexico H.B. 73 Biomarker Testing Insurance Requirements. This critical legislation would expand access to biomarker testing, essential to the rapid and accurate diagnosis of autoimmune and immune-mediated conditions, to the most vulnerable communities.
Letter in Support of H.R. 830 the HELP Copays Act
February 2023 – The Autoimmmune Association signed on to a letter from the All Copays Count Coalition thanking Rep. Buddy Carter (R-GA-01), Rep. Nanette Barragán (D-CA-44), Rep. Yvette Clarke (D-NY-09), Rep. Brian Fitzpatrick (R-PA-01), Rep. Bonnie Watson Coleman (D-NJ-12), Rep. Mariannette Miller-Meeks (R-IA-01), and Rep. Diana DeGette (D-CO-01) for introducing H.R. 830 the HELP Copays Act in the U.S. House of Representatives.
Letter to Establish Office of Autoimmune Disease Research
December 2022 – The Autoimmune Association sent a letter, co-signed by 36 patient organizations, to the House and Senate appropriation committees calling upon them to pass a final appropriations bill that includes a recommendation that an Office of Autoimmunity be established within the National Institutes of Health. This office would be critical in developing a comprehensive, transparent, and strategic approach to understanding autoimmune disease and funding additional research.
Take action for autoimmune disease
Immediate action is often needed when Congress or your state legislature is voting on important legislation. Contact your legislators on critical issues and make your voice heard! This one step can truly make a significant impact.